UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549
                                  _____________

                                    Form 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

      Date of Report (Date of earliest event reported): May 29, 2009


                              OCEAN BIO-CHEM, INC.
               (Exact name of registrant as specified in charter)

         Florida                       0-11102                   59-1564329
(State or Other Jurisdiction    (Commission File Number)       I.R.S. Employer
     of Incorporation)                                       Identification No.)

               4041 S.W. 47 Avenue, Fort Lauderdale, Florida 33314
                (Address of principal executive office Zip Code)

                                 (954) 587-6280
               Registrant's telephone number, including area code:

                                 Not Applicable
          (Former name or former address, if changes since last report)

Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions:

     [ ] Written  communications  pursuant to Rule 425 under the  Securities Act
(17 CFR 230.425)

     [ ] Soliciting  material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)

     [ ]  Pre-commencement  communications  pursuant to Rule 14d-2(b)  under the
Exchange Act (17 CFR 240.14d-2(b))

     [ ]  Pre-commencement  communications  pursuant to Rule 13e-4(c)  under the
Exchange Act (17 CFR 240.13e-4(c))




Item 7.01 Regulation FD Disclosure:

     On May 29, 2009, the Registrant  through its wholly owned subsidiary,  Star
brite  Distributing,  Inc.  initiated a law suit against ValvTect alleging false
advertising against one of its products.

The following is a Press Release that was published on such date:

     Fort Lauderdale, Florida-based Star brite, manufacturer of Star Tron Enzyme
Fuel treatment, has reluctantly filed a Federal lawsuit in the Southern District
of Florida against ValvTect Petroleum Products of Northbrook, Illinois. The suit
seeks  injunctive  relief and damages caused by ValvTect's  false and misleading
claims against Star Tron in ValvTect's Ethanol Gasoline Treatment advertising.

     Star brite CEO Peter  Dornau says "We would have  preferred to avoid taking
this step, but we had no choice given the confusion being spread among consumers
by ValvTect with these false and  misleading  claims.  Rather than selling their
product  on its own  merits or  customer  acceptance,  ValvTect  attacked  a few
aspects  of Star Tron,  a fuel  additive  that has a very  broad  functionality,
extremely high customer acceptance and strong brand loyalty."

     ValvTect's advertisements and website claim "Industry Tests Proved ValvTect
Outperformed  Star  Tron."  However,  the  results  reported  are  false and are
interpreted incorrectly.

     ValvTect  hand-picked  tests that are conducted at extreme  temperatures in
excess  of  200  degrees  F;  because  Star  Tron's   enzymes  are  impaired  at
temperatures over 200 degrees F. Please note that these  temperatures are far in
excess of conditions that any recreational boater would ever encounter. However,
despite these extreme  conditions,  when Star brite commissioned  Intertek Caleb
Brett,  one of the nation's leading fuel analysis  laboratories,  to conduct the
same tests,  Star Tron  actually tied or exceeded  ValvTect's  product in almost
every instance. When Star brite commissioned additional tests and had several of
the original tests modified to replicate  more realistic  conditions,  Star Tron
readily outperformed ValvTect's product.

     In closing,  please note that  ValvTect  continues to refuse to provide its
test data or identify the "independent  laboratory"  that purportedly  conducted
their  testing.  Attached  to this  message  are the real  results for the tests
reported by ValvTect as well as the additional tests commissioned by Star brite.



     For  more   information,   please   refer  to  the  Star  Tron  website  at
www.startron.com or contact Bill Lindsey, Star brite Vice President of Marketing
at (954) 587-6280 or via e-mail at blindsey@starbrite.com

                                   SIGNATURES

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.


                                           Ocean Bio-Chem, Inc.


June 2, 2009                               /s/ Jeffrey S. Barocas
                                           -----------------------------
                                           Jeffrey S. Barocas
                                           Vice President - Finance and
                                           Chief Financial Officer